Overcoming Clinical Supply Chain Challenges In Investigator Initiated Studies
Source: Almac Group
Investigator Initiated Studies (IIS) play an important role in helping pharmaceutical sponsor companies better understand their drugs. However, managing these studies presents unique and complex clinical supply chain challenges. In this webinar, Almac’s clinical supply experts address these challenges and provide insight into how to best manage investigator initiated clinical studies.
This webinar will discuss:
- Best practices for addressing the potential challenges in ensuring IIS drug supply availability
- The current IIS landscape: the increase in scale and complexity of IIS programs
- Demand planning and forecasting of drug supply considerations at an individual study or program level
- Optimizing pack design and labelling strategies for IIS
- IIS regulatory considerations
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Almac Group
This website uses cookies to ensure you get the best experience on our website. Learn more